Disclosures for "Development of a MATLAB-based Toolkit to Quantify Neurodegenerative Histopathology Markers Applied to the Evaluation of a CRISPR-based Therapeutic for Alzheimer’s Disease")
-
Mr. Satyadev has received research support from National Academy of Medicine. Mr. Satyadev has received personal compensation in the range of $10,000-$49,999 for serving as a CEO with The Youth Movement Against Alzheimer's.
-
Dr. Aulston has nothing to disclose.
-
Miss Branes has nothing to disclose.
-
Miss Checka has nothing to disclose.
-
Dr. Roy has stock in CRISPRAlz. The institution of Dr. Roy has received research support from Beam Therapeutics. Dr. Roy has received intellectual property interests from a discovery or technology relating to health care.